NASDAQ:UTRS

Minerva Surgical Stock Insider Trading

Healthcare > Medical - Healthcare Information Services

Buy UTRS

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Minerva Surgical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 56.58M and sold 126.82M UTRS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	56.58M shares
● Sell	126.82M shares
73% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 01, 2023 Buy	Common Stock	Cohen Daniel Director	Director	0 Value: $0
Mar 01, 2023 Buy	Common Stock	Cohen Daniel Director	Director	0 Value: $0
Feb 09, 2023 Buy	Common Stock P-Purchase	New Enterprise Associates 13 Lp 10 Percent Owner	10% Owner	24 437 927 Value: $5.00M
Feb 09, 2023 Buy	Common Stock P-Purchase	New Enterprise Associates 13 Lp 10 Percent Owner	10% Owner	24 437 927 Value: $5.00M
Feb 09, 2023 Buy	Common Stock	Accelmed Partners Ii L.p. 10 Percent Owner	10% Owner	0 Value: $0
Feb 09, 2023 Buy	Common Stock	Geiger Uri	Director	0 Value: $0
Feb 09, 2023 Buy	Common Stock	Geiger Uri	Director	0 Value: $0
Feb 09, 2023 Buy	Common Stock	Accelmed Partners Ii L.p. 10 Percent Owner	10% Owner	0 Value: $0
Jan 02, 2023 Buy	Common Stock J-Other	Usen Todd Chief Executive Officer	CEO / President	0 Value: $0
Jan 02, 2023 Buy	Common Stock J-Other	Usen Todd Chief Executive Officer	CEO / President	0 Value: $0
Jul 19, 2022 Buy	Common Stock A-Award	Sung Derrick	Director	86 956 Value: $200.0K
Jul 19, 2022 Buy	Common Stock A-Award	Sung Derrick	Director	86 956 Value: $200.0K
Jul 19, 2022 Buy	Common Stock J-Other	Sung Derrick	Director	0 Value: $0
Jul 19, 2022 Buy	Common Stock J-Other	Sung Derrick	Director	0 Value: $0
Jun 10, 2022 Buy	Common Stock A-Award	Behbahani Ali	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Jaffe Ross A Md	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Renzi David	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Hunt Niquette L.	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Coste Catherine	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Anderson Jill	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Anderson Jill	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Coste Catherine	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Hunt Niquette L.	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Renzi David	Director	49 792 Value: $120.0K
Jun 10, 2022 Buy	Common Stock A-Award	Jaffe Ross A Md	Director	49 792 Value: $120.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MINERVA SURGICAL, INC.

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bl...

Read Full Profile Here